Bangalore BIO 2005
The Department of IT and Biotechnology, Government of Karnataka and Vision
Group on Biotechnology will jointly organize Bangalore BIO 2005 from April
22-24, 2005. The core theme of the conference will be 'Bio-technology for
billion people.' The three-day conference will be addressed by over 50
speakers from all across the globe. About 700 delegates are expected to attend
the conference.
For further details, contact: info@bangalorebio2005.com
or biodir@bangalorebio.com or
ceo@kbdc.org
BIO 2005
Biotechnology Industry Organization's (BIO) 2005 Annual
International Convention will be held at the Pennsylvania Convention Center in
Philadelphia on June 19-22, 2005. This year's conference is hosted by the
tri-state region of Pennsylvania, New Jersey, and Delaware. More than 18,000
biotech executives, investors, journalists, policy makers and scientists from
more than 60 countries are expected to attend.
The convention will feature greater overseas representation with two
international plenary sessions, country seminars with 16 countries presenting
the latest developments in national biotechnology policies, and a ministerial
seminar with federal level ministers from at least four countries. BIO will host
a record number of high ranking international dignitaries leading national
delegations from more than 60 countries. The program includes more than 150
educational sessions and workshops on topics including industrial and
environmental applications, finance, science, manufacturing, food and
agriculture.
For more details, contact: info@bio.org
BIO VentureForum East 2005
The Biotechnology Industry Organization (BIO), in partnership with 12
state biotechnology associations and BIOTECanada will organize BIO VentureForum
East 2005 at the Intercontinental Hotel-Buckhead, Atlanta, Georgia on May 9-11,
2005. The conference will bring venture capitalists together with promising
seed, early- and late-stage private biotechnology product and platform companies
from the East Coast. It will showcase 120 individual company presentations to
leading North American venture capital firms in the life sciences field.
Workshops and plenary sessions will be offered on trends in the biotech
industry, with special focus on key success factors for early stage companies,
R&D, market trends, and financing. In addition, there will be formal and
informal networking opportunities with industry CEOs and venture capital
leaders.
To ensure high quality deal flow, an advisory board made up of 30 equity
capital leaders, will review and evaluate the corporate profiles of companies
through an application process. Selected entrepreneurs will also attend regional
BIO Venture Forum Boot Camps to be intensively coached and provided with the
tools needed to refine their presentations and grow their enterprises.
For more details, contact: gbutera@bio.org
or ccook@bio.org
World Congress on Industrial Biotechnology
The Biotechnology Industry Organization (BIO), American Chemical
Society (ACS) and the National Agriculture Biotechnology Council (NABC) will
organise the second annual World Congress on Industrial Biotechnology and
Bioprocessing on April 20-22 in Orlando, Florida. The conference will be geared
toward a diverse base of participants from biotechnology, chemical and other
industries, to government and academia. It is meant to provide a unique forum
for interdisciplinary interaction and networking. The three-day event will
feature technical sessions for business, academic and research-related
presentations on topics such as biotechnology in manufacturing and synthesis and
industrial biotech in pharmaceuticals.
For further details, contact: worldcongress@bio.org
BioSquare 2005
BioSquare 2005, a three-day event which will commence on April 13, 2005, will
offer a unique opportunity for the top management of biotechnology companies to
meet with key research and business development executives from the
pharmaceutical, nutraceutical, agriculture, food, and finance industries.
BioSquare will be held on the occasion of the next World Life Sciences Forum,
BioVision 2005. BioSquare and BioVision will take place in conjunction with
several other events such as the Nobel Laureates' Day, BioVision.Nxt and Europ@BioVision.The
unique combination of these events represents the largest gathering at the
highest level of key opinion-leaders and decision-makers from the World of Life
Sciences.
For more information, contact: tvoigt@ebdgroup.com
Bio-Collaborations Asia
IBC Life Sciences will organize Bio-Collaborations Asia at the Boston
Park Plaza Hotel, Boston, MA, on May 18-20, 2005. The conference will explore
the issues relating to building and growing a pharmaceutical or biotechnology
business in Asia. It will feature select case experiences of US and European
companies who have ventured into Asia, either through joint venture, licensing
or outsourcing collaborations. Conference speakers will examine the challenges,
the tribulations and the successes of these partnerships.
The conference will include focused sessions on IP and Regulatory concerns in China and India, value propositions for licensing, outsourcing and offshoring to Asia, best practices and case studies of successful collaborations between East and West.
IBC in association with The Federation of Indian Chambers of Commerce and
Industry (FICCI) will also organize a half-day "India Pharma Forum
2005" on May 18, 2005.
For more details, contact: inq@ibcusa.com
Phacilitate Vaccine Forum Spring 2005
Phacilitate's fourth annual Spring Vaccine Forum will be held on May 23-25,
2005 at Amsterdam, Netherlands. The conference will provide an ideal opportunity
for leaders from across the vaccines sector to meet, and to discuss solutions to
their common strategic, regulatory and technological challenges. A blend of
plenary presentations, workshops, breakout sessions and panel discussions will
make for a highly interactive conference which will be complemented by
networking over the course of the three days. The sessions will include
discussion on overcoming major current challenges in the development and
regulation of novel vaccines, vaccine safety reporting requirements and
initiatives and programs related to clinical trial conduct.
For more details, contact: nathalie@phacilitate.co.uk
BIO-Windhover 2005
BIO and Windhover Information will jointly organise BIO-Windhover 2005
at The Ritz-Carlton Washington DC, on April 25-27, 2005. The conference will
provide an exclusive platform for biotech and pharmaceutical business
development decision makers to have focused, meaningful conversations about
partnership opportunities. The conference will use a state-of-the-art scheduling
software to facilitate one-on-one meetings between potential partners. Over 300
senior pharmaceutical and biotech business development executives are expected
to attend the conference and over 1100 private, one-on-one meetings will be
arranged through scheduling software.
For more details, contact: ccampbell@bio.org
or sgreenberg@windhover.com
